Recent Developments in GLP-1 Agonists for Obesity Treatment | Retatrutide News

GLP-1 agonists, including Retatrutide, are being developed by Eli Lilly for obesity treatment. These drugs are part of a significant push to address obe...
Market News · October 11, 2026